Nanosonics (ASX:NAN) share price soars 17% on 'significant recovery'

Investors are clearly impressed with how the company has been performing.

| More on:
three excited doctors with hands in the air

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Nanosonics Ltd (ASX: NAN) share price is having a bumper start to the day after the company released its FY21 full-year results this morning.

Once coined "the next CSL Limited (ASX: CSL)", Nanosonics has struggled to live up to expectations following weak FY21 first-half and FY20 earnings. The Nanosonics share price fell 8.15% and 9.61%, respectively following the release of these results.

But today it's a different story with investors clearly pleased by how the company has been performing. At the time of writing, Nanosonics shares are trading 16.89% higher at $6.885.

Nanosonics share price rockets higher despite profit fall

Despite today's gains, the Nanosonics share price is still down by around 16% year to date. So this morning's rally will come as welcome news for shareholders. Key highlights of the company's FY21 performance include:

  • Revenue up 3.0% against the prior corresponding period (pcp) to $103.1 million.
  • Significant recovery in the FY21 second half, with revenue up 39% compared to the first half.
  • The global installed base rose 13% to 26,750 units.
  • Earnings before interest and tax was down 7% to $10.8 million.
  • Profit after income tax fell 15% to $8.6 million.

What happened for Nanosonics in FY21?

FY21 proved to be a challenging year for the Nanosonics share price.

But despite what could be seen as a relatively flat financial performance, today's results announcement focused on the narrative that the company experienced a "significant recovery" in the second half of FY21. The second-half recovery was driven by an improvement in market conditions and hospital procedure volumes recovering towards pre-COVID-19 levels.

Breaking down the company's revenue of $103.1 million, 1H21 revenues fell 11.3% on the pcp to $43.1 million, while 2H21 revenues bounced back 16.3%.

The recovery theme was reflected across the company's business divisions including consumables, services and capital.

Nanosonics continues to invest in its strategic growth agenda with operating expenses up 12% to $70.8 million. It cited that, as market conditions improved in the second half, Q4 expenses of $20.3 million represented 29% of total operating expenditure as the company returned to its intended investment run rate.

Management commentary

Nanosonics CEO and president Michael Kavanagh commented on the challenging year:

The 2021 financial year was an important year of progress where the Company successfully adapted to the global challenges associated with COVID-19. Despite varying constraints and disruptions, the Nanosonics team continued to progress many aspects of our strategic growth agenda. Significant growth was achieved in the second half of the year as market conditions improved. This saw total revenue growing 39% compared with the first half resulting from strong growth in the installed base as well as ultrasound procedures trending back towards pre-COVID-19 levels.

What's next for Nanosonics?

In comparison to many of its peers, the Nanosonics share price still has a lot of catching up to do in 2021. The S&P/ASX 200 Health Care Index (ASX: XHJ) is up 12% year to date.

Nanosonics has continued to increase its investments in infrastructure growth and market expansion across key geographic regions.

The company is currently finalising the registration of a wholly-owned foreign enterprise in China and preparing for regulatory submission to approve its trophon2 product for commercialisation.

Encouragingly, Nanosonics said that "Despite the inherent risks and uncertainties associated with COVID-19, in particular those emerging with different strains of the virus, Nanosonics remains optimistic that the improved market conditions will continue as vaccination numbers increase across all major markets."

Assuming that such trends continue, the company anticipates a return to double-digit growth in total revenue in FY22.

Nanosonics share price snapshot

As well as a lacklustre year-to-date performance, prior to today, the Nanosonics share price had also fallen by around 14% over the past twelve months. This morning's boost, however, has eradicated those losses to put the company's shares 0.2% higher for the past year. Based on the current share price, the company has a market capitalisation of around $1.8 billion.

Motley Fool contributor Kerry Sun has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended CSL Ltd. and Nanosonics Limited. The Motley Fool Australia owns shares of and has recommended Nanosonics Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Earnings Results

Man jumps for joy in front of a background of a rising stocks graphic.
Earnings Results

Catapult shines: 20% sales growth propels ASX tech stock to new 52-week high

A strong annual result from this tech player has caught investor attention.

Read more »

A man in his 30s holds his laptop and operates it with his other hand as he has a look of pleasant surprise on his face as though he is learning something new or finding hidden value in something on the screen.
Earnings Results

Xero share price leaps 8% on staggering earnings upheaval

A major turnaround in profitability is sending investors into a frenzy over Xero shares today.

Read more »

a construction worker sits pensively at his desk with his arm propping up his chin as he looks at his laptop computer while wearing a hard hat and visibility vest in a bunker style construction shed.
Materials Shares

Which ASX 200 stock just plunged 12% despite record full-year earnings?

It looks like an impressive report card but UBS doesn't like the FY25 guidance.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Earnings Results

ASX 200 tech stock lifts off on another record-setting half-year profit

Investors are bidding up the ASX 200 tech company following its half-year results.

Read more »

increasing rural asx share price represented by happy looking sheep
Earnings Results

Why is this ASX All Ords stock staying strong as profits crash 76%

How is this company's share price marching higher after mowing down more than three-quarters of its profits compared to a…

Read more »

Two men sit side by side on a couch with video game controls in their hands and expressive looks on their faces as they react to the action in front of them in a home setting.
Earnings Results

Guess which ASX 200 stock is surging 11% on an 'outstanding' result

This ASX gaming giant just posted a 17% jump in profits, and its shareholders are basking in the glory.

Read more »

Agricultural ASX share price on watch represented by farmer in field looking at tablet computer.
Earnings Results

Graincorp share price lifts off as dividend is maintained and debts plunge

ASX 200 investors are bidding up the Graincorp share price today. But why?

Read more »

Smiling elderly couple looking at their superannuation account, symbolising retirement.
Earnings Results

Why is this ASX 200 stock avoiding the market selloff and pushing higher?

Not all shares are falling with the market on Thursday.

Read more »